Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice.

Source:http://linkedlifedata.com/resource/pubmed/id/20599427

Download in:

View as

General Info

PMID
20599427